1-2 of 2
John H. Fetting
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

Roisin M. Connolly, Huili Li, Rachel C. Jankowitz, Zhe Zhang, Michelle A. Rudek, Stacie C. Jeter, Shannon A. Slater, Penny Powers, Antonio C. Wolff, John H. Fetting, Adam Brufsky, Richard Piekarz, Nita Ahuja, Peter W. Laird, Hui Shen, Daniel J. Weisenberger, Leslie Cope, James G. Herman, George Somlo, Agustin A. Garcia, Peter A. Jones, Stephen B. Baylin, Nancy E. Davidson, Cynthia A. Zahnow, Vered Stearns
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (11): 2691–2701.
https://doi.org/10.1158/1078-0432.CCR-16-1729
Published: 31 May 2017
View article titled, Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Open the PDF for Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study in another window
Includes: Supplementary data
Journal Articles

A Phase II Study of the Polyamine Analog N 1, N 11-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer

Antonio C. Wolff, Deborah K. Armstrong, John H. Fetting, M. Katherine Carducci, Carol D. Riley, John F. Bender, Robert A. Casero, Jr., Nancy E. Davidson
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5922–5928.
Published: 15 December 2003
View article titled, A Phase II Study of the Polyamine Analog <em>N</em> <sup>1</sup>, <em>N</em> <sup>11</sup>-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer
Open the PDF for A Phase II Study of the Polyamine Analog <em>N</em> <sup>1</sup>, <em>N</em> <sup>11</sup>-Diethylnorspermine (DENSpm) Daily for Five Days Every 21 Days in Patients with Previously Treated Metastatic Breast Cancer in another window